Circassia Pharmaceuticals plc

thinkerdoer have been producing annual reports for Circassia since their entry to the London Stock Exchange in 2014 (the biggest for any biotech for decades).

Working with Chief Executive Steve Harris and Head of Corporate Communications Rob Budge, we shaped the investor messaging; diseases know no borders, the major opportunity, and how they are delivering on their potential as this world-class speciality biopharmaceutical business continues to deliver against its strategy.